How can it help with weight loss
A 2026 real-world study presented at the European Congress on Obesity found that 88% of participants taking GLP-1 medications fell short of recommended protein intake
But its, also its a bit different
Is this study as reliable as the Pei 2024 meta-analysis with 1,458 patients
Subscribe here: To view or add a comment, sign in Ingredion Will Pay $3.6 Billion for Britains Tate & Lyle, Stitching Together a $9.9 Billion Sweetener Giant Built for the Ozempic Diet Ingredion, the Chicago-headquartered specialty food-ingredients group, has agreed to buy Britain's Tate & Lyle for 2.7 billion, equivalent to $3.6 billion, creating a $9.9 billion combined business pointed directly at the sugar-replacement and protein-fortified categories that the GLP-1 diet drug era is reshaping the global food economy around
If the problem isnt dental, well help point you toward the medical specialist who can